https://www.selleckchem.com/products/vx-661.html
High fructose intake has been implicated in obesity and metabolic syndrome, which are related to increased cardiovascular mortality. However, few studies have experimentally examined the role of renin-angiotensin system blockers and calcium channel blockers (CC in obesity. We investigated the effects of valsartan (an angiotensin II receptor blocker) and amlodipine (a CC on lipolysis through the potential mechanism of PU.1 inhibition. We observed that high fructose concentrations significantly increased adipose size and triglyceride,
Like
Comment
Share
